Sharps Compliance Corp

Sharps Compliance — Credit Suisse 13th Annual Global Services Conference (March 2011)

20 slides from Sharps Compliance's conference presentation, Mar 14, 2011

  1. Slide 1: Sharps Compliance Corp.

    Slide 1: Sharps Compliance Corp.

    800.772.5657 / www.sharpsinc.com Sharps Compliance Corp. NASDAQ: SMED David P. Tusa Chief Executive Officer and President Diana P. Diaz Vice President and Chief Financial Officer Credit Suisse 13 th Annual Global Services Conference March 14, 2011

  2. Slide 2: Safe Harbor Statement

    Slide 2: Safe Harbor Statement

    800.772.5657 / www.sharpsinc.com Safe Harbor Statement These slides contain (and the accompanying oral discussion will contain) “ forward- looking statements ” within the meaning of the Private Securities Litigation Reform Act of 1995. The words “ believe ” , “ estimate ” , “ anticipate ” , “ projec

  3. Slide 3: Sharps Compliance

    Slide 3: Sharps Compliance

    800.772.5657 / www.sharpsinc.com Sharps Compliance NASDAQ: SMED¹ Market capitalization² $83.7 million Recent price² $5.62 52-week range² $7.87 - $3.65 Avg. daily trading volume (3 mos.) 131,568 ³ Ownership as of December 31, 2010 ¹ Listed 5/6/09; formerly OTCBB: SCOM ² As of 3/7/11 Total shares outs

  4. Slide 4: Sharps Recovery System Sharps Disposal Legislation for Self-Injectors

    Slide 4: Sharps Recovery System Sharps Disposal Legislation for Self-Injectors

    Sharps Recovery System™ Sharps Disposal Legislation for Self-Injectors Source: (1) Centers for Disease Control and Prevention ♦ Proposed or enacted legislation that covers 30% of the U.S. population Medical Professional Sharps Recovery System™ Sharps Recovery System™ $1 Billion Unregulated Market Op

  5. Slide 5: TakeAway Recovery Systems Unused Medication Disposal Legislation

    Slide 5: TakeAway Recovery Systems Unused Medication Disposal Legislation

    TakeAway Recovery™ Systems Unused Medication Disposal Legislation ♦ Proposed or enacted legislation that covers 65% of the U.S. population $1 Billion Market Opportunity ♦ 40% of dispensed medications from 4 billion prescriptions go unused annually ♦ Estimated 200 million pounds of medications go unu

  6. Slide 6: Vertically Integrated Solutions Provider

    Slide 6: Vertically Integrated Solutions Provider

    800.772.5657 / www.sharpsinc.com Vertically Integrated Solutions Provider SharpsTracer™ MedTracer™ Fully integrated including distribution, online tracking, treatment and customer reporting Two distribution facilities: Texas and Georgia Regulatory compliant tracking and documentation system: provide

  7. Slide 7: Key Markets: Retail Pharmacies

    Slide 7: Key Markets: Retail Pharmacies

    Key Markets: Retail Pharmacies ü Drives foot traffic and customer interaction ü Unused medication envelope solution now has a shelf presence in some of the nation’s largest drug chains ü Total Market Opportunity: $40 million (TakeAway envelope only) Sharps Recovery System™ TakeAway Recovery™ System

  8. Slide 8: Key Markets: Professional

    Slide 8: Key Markets: Professional

    800.772.5657 / www.sharpsinc.com Key Markets: Professional Launched inside sales initiative in January 2010 Driving Awareness Recurring Revenue Opportunities Educating the Market ü Estimated 800,000 professional offices across the U.S. ü Regulated industry Sharps Recovery System™ ü Total Market Oppo

  9. Slide 9: Key Markets: Core Government - U.S. Department of Veterans Affairs Pilot Program

    Slide 9: Key Markets: Core Government - U.S. Department of Veterans Affairs Pilot Program

    Key Markets: Core Government U.S. Department of Veterans Affairs Innovative Pilot Program ♦ Launched February 2010 in four state region ♦ Provides medical waste and unused medication disposal solutions ♦ Program expanded to eight geographic regions due to positive response ♦ Opportunity for strong r

  10. Slide 10: Key Markets: Government Contracts

    Slide 10: Key Markets: Government Contracts

    Key Markets: Government Contracts Sharps Proprietary Medical Waste Management System Opportunity to expand to cover more people and to cover unused medications ♦ Rapid-deployment solution in the event of an emergency ♦ Increasingly recognized part of emergency preparedness program ♦ Full service out

  11. Slide 11: Channels to Market

    Slide 11: Channels to Market

    800.772.5657 / www.sharpsinc.com Channels to Market Increased Brand Awareness Retail Hospitality Assisted living Commercial / Industrial Pharmaceutical Manufacturers Government Managed Care Organizations Dentists Doctors Veterinarians Home Healthcare Pharmacies

  12. Slide 12: Financial Highlights

    Slide 12: Financial Highlights

    800.772.5657 / www.sharpsinc.com Financial Highlights

  13. Slide 13: Solid Business Model

    Slide 13: Solid Business Model

    800.772.5657 / www.sharpsinc.com Solid Business Model Recurring Revenue Early Market Penetration First Mover Advantage Unique Operating Leverage

  14. Slide 14: Billings by Markets Segment

    Slide 14: Billings by Markets Segment

    Billings by Markets Segment FY 2008 Billings $13.2 million

  15. Slide 15: Full-year Results

    Slide 15: Full-year Results

    800.772.5657 / www.sharpsinc.com ($ in millions) Full-year Results Core Revenue $39.2 $17.6 $20.3 Gross Margin Operating Margin Net Income * Excludes special charge of $512 thousand and, for net income, an unusual tax benefit of $1.8 million. ** Excludes special charge of $570 thousand.

  16. Slide 16: Quarterly Performance

    Slide 16: Quarterly Performance

    800.772.5657 / www.sharpsinc.com Quarterly Performance ($ in millions) Core Revenue Gross Margin Operating Margin Net Income $16.0 $3.6 $4.2 $5.2 $4.6 * Excludes Q1 FY2011 special charge of $570 thousand

  17. Slide 17: Strong Balance Sheet

    Slide 17: Strong Balance Sheet

    Strong Balance Sheet Cash and Cash Equivalents $17.8M Shareholder Equity Growth Q2 09 vs. Q2 11 297% Line of Credit $5.0M (As of and for the period ending December 31, 2010) No debt as of 12/31/10

  18. Slide 18: Waste Conversion Process

    Slide 18: Waste Conversion Process

    800.772.5657 / www.sharpsinc.com Waste Conversion Process™ ü No landfills required ü Creates a useful raw material ü Safe - 99.999% sterilized, and completely safe to handle ü Environmentally responsible - reduces carbon footprint ü Facilitates corporate environmental initiatives Patent-pending proc

  19. Slide 19: Investment Highlights

    Slide 19: Investment Highlights

    800.772.5657 / www.sharpsinc.com Investment Highlights

  20. Slide 20: Definitions

    Slide 20: Definitions

    800.772.5657 / www.sharpsinc.com Definitions • Sharps Recovery System™ (formerly Sharps Disposal by Mail System®) A cost-effective and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets , and other small quantities of bio hazardous waste. The disposal solution is id

Source: SEC EDGAR · 8-K filed Mar 14, 2011

More decks from Sharps Compliance Corp